Of more than 2500 trials analyzed, 21% were randomized.
Children prescribed a medication containing a phthalate had a 19% higher risk of developing any childhood cancer.
The biosimilars proved as effective as the original biologics in all cancers studied.
Sugemalimab demonstrated efficacy in combination with chemotherapy and as consolidation after chemoradiotherapy.
A meta-analysis suggests that patients with cancer may be twice as likely as non-cancer patients to have a breakthrough infection after being fully vaccinated.
Most patients with solid tumors demonstrate immune responses to COVID-19 vaccines, but a subset of patients do not.
More research is needed before radiomics can be used in clinical practice, according to researchers.
Researchers found associations between epigenetic age acceleration, inflammation, and fatigue in cancer patients.
Black cancer patients were 44% less likely than White patients to enroll in a portal that provides access to electronic health records.
The immune cells in the microenvironment can reign in myeloma cells but become suppressed and dysregulated during disease progression.
